The Peptide Index · Flagship Evidence Profile · Updated October 2026

GLUTATHIONE

One of the body’s most important antioxidant molecules—and one of the easiest to oversimplify.

Glutathione is a naturally produced tripeptide central to redox biology. Its endogenous role is well established; the evidence for supplemental and injectable uses depends heavily on formulation, route, population and outcome.

Editorial verdict
Strong biology.
Route-dependent evidence.

The molecule is important. That does not make every glutathione intervention equally proven.

Human evidence
●●●○○
Multiple human studies; outcomes vary by route
Preclinical evidence
●●●●●
Deep redox and cellular biology
Mechanistic rationale
●●●●●
Central endogenous antioxidant system
Community signal
●●●●○
High wellness and injectable interest
The Gap
MEANINGFUL
Mechanism often outruns outcome-specific evidence
Editorial ratings are orientation tools. Evidence strength depends on the specific outcome, population, formulation and route studied.
01 / WHAT IT IS

A small peptide.
A central redox system.

Glutathione (GSH) is an endogenous tripeptide made from glutamate, cysteine and glycine and is central to cellular redox balance.

Its biology is unusually well established. The harder question is whether taking glutathione from outside the body—oral, liposomal, sublingual or intravenous—reliably produces meaningful clinical outcomes.

In Plain English

Glutathione is one of the body’s primary antioxidant-defense molecules, helping cells manage oxidative stress and maintain normal detoxification and repair processes.

02 / HUMAN EVIDENCE

Real biology. Mixed translation.

Human supplementation studies do not tell one simple story. A 2011 randomized trial found no significant change in oxidative-stress biomarkers after four weeks of standard oral glutathione, while a six-month randomized trial later found increased glutathione stores in several body compartments. More recent work continues to show that formulation changes absorption: a 2026 randomized crossover pilot found higher systemic exposure from a micellar formulation than standard oral glutathione.

That is the central Glutathione story: evidence for the molecule’s biological importance is strong; evidence that a particular supplemental route or formulation produces a particular health outcome is much more variable.
03 / ROUTE MATTERS

“Glutathione” is not one intervention.

OralHuman studies show variable absorption and biomarker effects. Formulation and study duration appear to matter.
Liposomal / micellarDesigned to improve oral delivery. Early pharmacokinetic data support formulation-dependent differences, but higher blood exposure is not the same as proven clinical benefit.
IntravenousProduces a very different exposure profile. Broad wellness, detoxification or cosmetic claims should not be inferred from glutathione’s endogenous biology.
Skin / beautySmall studies and reviews report some pigmentation signals, but recent reviews emphasize limited, heterogeneous evidence and particular uncertainty around IV cosmetic use.
04 / CLAIM VS EVIDENCE

The phrase “master antioxidant” can mislead.

“Glutathione is biologically important.”Strongly supported. It is a central endogenous redox molecule.
“Taking it detoxes the body.”Too broad. Glutathione participates in detoxification biology, but that does not establish a generalized clinical “detox” effect from supplementation.
“Oral glutathione doesn’t absorb.”Too absolute. Human studies show that absorption and glutathione-store changes can occur, and formulation matters.
“IV is automatically better.”Unsupported. Greater systemic exposure does not by itself prove superior outcomes or safety for wellness use.
04A / COMMUNITY PROTOCOL SIGNAL

What people are actually reporting.

Glutathione has no single wellness-injection protocol. Community reports vary widely by route, amount, frequency and goal.

Commonly reported injectable range
~200–300 mg
Per administration appears repeatedly in current community discussions.

Examples include 200 mg IM several times per week and roughly 300 mg subcutaneous daily. Higher amounts also appear online, but the dispersion is large enough that presenting a single “standard dose” would be misleading.

Frequency
2–3× weekly → daily

Reports span intermittent injections through daily use. There is no clear community consensus and no standardized wellness protocol.

Route
IM · SubQ · IV

IM and subcutaneous use are both discussed in peptide communities; IV use is prominent in clinics. Route changes exposure, convenience and tolerability and should not be treated as interchangeable.

What users mention
Energy · clarity · recovery

Users commonly discuss subjective energy, mental clarity, recovery and antioxidant or “detox” goals. These reports do not establish efficacy for those outcomes.

Community consistency: LOWThe molecule is popular, but reported protocols are highly variable and goal-dependent.
What the science actually supports

Glutathione biology is well established, but human evidence does not establish a universal injectable wellness dose or schedule. Route-specific clinical research exists in particular medical contexts; that should not be generalized into an anti-aging, recovery or detox protocol.

Editorial rule: The range above describes what people report doing—not a recommended dose. Injectable glutathione protocols have not been standardized for general wellness use.
05 / THE GAP

Strong mechanism. Outcome-dependent evidence.

THE GAP
MEANINGFUL

Glutathione’s endogenous biology is not in question. The gap appears when that biology is translated into broad claims about supplementation, injections, detoxification, recovery, anti-aging or cosmetic outcomes without route- and outcome-specific evidence.

Editorial note: BIOHACKING. EVOLVED. is an educational publication, not a medical provider. This page does not provide dosing recommendations, sourcing, treatment or prescribing guidance. Evidence, indications and regulatory status can change; source dates matter.